Current Report on Form 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
---------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 19, 1999
INAMED CORPORATION
------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-9741 2270920629
-------- ------ ----------
(State or other (Commission File (IRS Employer
jurisdiction of incorporation) Number) Identification No.)
700 Ward Drive
Santa Barbara, California 93111
--------------------------------------
Address of principal executive offices
Registrant's telephone number, including area code: 805/692-5400
-------------------------------------------------------------
(Former name or former address, if changed since last
report.)
<PAGE>
Item 5. OTHER EVENTS.
On March 19, 1999, INAMED Corporation (the "Company") issued a press
release announcing that John F. Doyle, David A. Tepper and James E. Bolin have
been elected to the Company's board of directors. The press release is attached
as Exhibit 99.1 to this Current Report and incorporated herein by reference.
Item 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) EXHIBITS
99.1 Press release of INAMED Corporation dated March 19, 1999.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INAMED CORPORATION
Dated: March 19, 1999 By:/s/ RICHARD G. BABBITT
----------------------
Name: Richard G. Babbitt
Title: Chairman and CEO
<PAGE>
EXHIBIT INDEX
99.1 Press Release of INAMED Corporation dated March 19, 1999.
Exhibit 99.1
INAMED "Innovation and Medicine" INAMED CORPORATION
700 Ward Drive
Santa Barbara, CA 93111
Telephone (805) 692-5400
Facsimile (805) 692-5441
COMPANY CONTACTS: Jeff Barber
(805) 692-5400
Ilan K. Reich
(212) 626-6800
INAMED CORPORATION ANNOUNCES NEW BOARD MEMBERS
March 19, 1999--Santa Barbara, California--INAMED Corporation (OTC Bulletin
Board: IMDC) announced today that John F. Doyle, David A. Tepper and James E.
Bolin have been elected to the company's Board of Directors.
Mr. Doyle has previously worked with IBM and Craig Corporation in executive and
sales and marketing positions. He served as the Chairman and Chief Executive
Officer of Pioneer Electronics (USA) Inc. from 1971 to 1986. He has served on
the Board of Directors of consumer groups and also business and philanthropic
organizations. Mr. Doyle holds a Bachelor of Arts from Miami University of Ohio.
Mr. Tepper has been President of Appaloosa Partners Inc. since its formation in
1993. He was previously head trader in the High Yield Department of Goldman,
Sachs & Co. He also has been employed by Keystone Funds and Republic Steel. Mr.
Tepper holds an MBA from Carnegie Mellon University and a Bachelor of Arts with
honors in Economics from the University of Pittsburgh.
Mr. Bolin has been a Vice President and Secretary of Appaloosa Partners Inc.
since 1995. He has previously been a Vice President and Director of Corporate
Bond Research at Goldman, Sachs & Co. He also worked at Smith Barney, Harris
Upham in the Fixed Income Research Department. Mr. Bolin holds a Bachelor of
Arts from Washington University in St. Louis and an MBA in accounting and
finance from University of Missouri-St. Louis.
Richard G. Babbitt, the Company's chairman and chief executive officer, stated:
"We are pleased to announce these additions to our Board of Directors. Jack
Doyle brings with him a wealth of business knowledge and will serve as a
contributor to our continued long-term growth. David Tepper and Jim Bolin bring
to us the results of years of finance experience, both in a corporate world and
also in private business. They will continue to be instrumental in our financing
and acquisition capabilities."
INAMED is a global surgical and medical device company engaged in the
development, manufacturing and marketing of medical devices for the plastic and
reconstructive, bariatric and general surgery markets.
# # #
